The pharmaceutical industry constantly seeks innovative solutions to combat diseases, and the synthesis of cutting-edge drugs relies heavily on specialized chemical intermediates. Among these, N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea (CAS 796848-79-8) plays a pivotal role, particularly in the development of targeted cancer therapies. As a leading pharmaceutical intermediate supplier, we understand the significance of such compounds and are dedicated to providing consistent, high-quality materials for your critical applications.

Understanding the Significance of N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea

N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea is an organic compound that serves as a crucial building block in the complex chemical synthesis pathways for various Active Pharmaceutical Ingredients (APIs). Its precise molecular structure and functional groups are integral to forming the core of molecules like Lenvatinib, a multi-kinase inhibitor widely used in the treatment of several types of cancer, including thyroid, kidney, and liver cancer. The reliable supply of this intermediate directly impacts the efficient production of these life-saving medications.

Manufacturing and Sourcing Considerations

As a key intermediate, the demand for N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea is driven by the global need for effective cancer treatments. For researchers and pharmaceutical manufacturers, securing a dependable source is paramount. When you seek to purchase this compound, consider the following:

• Purity and Consistency: The synthesis of pharmaceuticals requires intermediates with exceptionally high purity levels (often ≥98.0%) to ensure the efficacy and safety of the final drug product. Consistency across batches is equally important for reproducible results in manufacturing processes.
• Manufacturing Expertise: Partner with manufacturers that possess advanced synthesis capabilities and a deep understanding of pharmaceutical quality standards. Certifications like GMP and ISO are indicators of robust manufacturing processes.
• Competitive Pricing: Efficient production and economies of scale allow for competitive prices, making advanced therapies more accessible. As a dedicated supplier in China, we strive to offer cost-effective solutions without compromising on quality.
• Technical Documentation: Access to comprehensive technical data, including Certificates of Analysis (CoA) and Material Safety Data Sheets (MSDS), is essential for regulatory compliance and safe handling.

The NINGBO INNO PHARMCHEM CO.,LTD. Advantage

At NINGBO INNO PHARMCHEM CO.,LTD., we pride ourselves on being a leading supplier of high-quality pharmaceutical intermediates. Our commitment to excellence ensures that N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea is available with the purity and reliability your projects demand. We understand the critical nature of pharmaceutical synthesis and are dedicated to supporting your efforts in bringing advanced therapies to market. By choosing us as your manufacturer and supplier, you ensure a stable, high-quality source for this indispensable intermediate.

For those looking to buy N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea, our company provides a dependable pathway to acquiring this vital component, supporting innovation in oncology drug development and manufacturing.